Brett A. Giffin - Nov 8, 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Commercial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Nov 8, 2023
Transactions value $
$0
Form type
4
Date filed
11/28/2023, 04:05 PM
Previous filing
Nov 28, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +33 +106.45% 64 Nov 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -33 -49.25% $0.00 34 Nov 8, 2023 Common Stock 33 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On February 26, 2022 the reporting person was granted 100 RSU's that vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.